Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 20,503	$ 19,180
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	(357)	(817)
Depreciation, amortization and accretion, net	5,338	3,485
Change in cash surrender value of bank owned life insurance	(1,121)	(926)
Change in bank owned life insurance	0	(715)
Stock-based compensation expense	606	307
Operating lease payments	(836)	(781)
Loss on investment securities, net	0	46
(Gain) loss on sales and write downs of other real estate owned, net	(70)	71
Gain on sale of loans held for sale, net	(233)	(207)
Increase in accrued interest receivable	(2,585)	(372)
Increase in accrued interest payable	910	1,378
Origination of loans held for sale	(10,448)	(12,191)
Proceeds from sale of loans held for sale	10,844	11,737
Decrease in other assets	10,537	1,867
Decrease in other liabilities	(4,040)	(1,757)
Net cash provided by operating activities	29,048	20,305
Cash flows from investing activities:
Purchases of certificates of deposit investments	(2,275)	(245)
Proceeds from sales of securities available-for-sale	0	6,483
Proceeds from maturities of securities available-for-sale	21,621	19,250
Purchases of securities available-for-sale	(994)	(1,063)
Purchase of securities held-to-maturity	0	(25)
Income increasing amortized cost of HTM securities	(11)	0
Net decrease in loans	80,542	65,541
Purchases of premises and equipment	(1,480)	(941)
Proceeds from sales of other real property owned	0	734
Net cash provided by investing activities	97,403	89,734
Cash flows from financing activities:
Net increase (decrease) in deposits	119,277	(226,223)
(Decrease) increase in repurchase agreements	(3,002)	7,250
Proceeds from FHLB advances	0	170,000
Repayment of FHLB advances	(25,000)	(40,000)
Proceeds from issuance of common stock	382	336
Purchase of treasury stock	0	(5)
Dividends paid on common stock	(5,471)	(4,696)
Net cash provided by (used in) financing activities	86,186	(93,338)
Increase in cash and cash equivalents	212,637	16,701
Cash and cash equivalents at beginning of period	143,064	152,433
Cash and cash equivalents at end of period	355,701	169,134
Cash paid during the period for:
Interest	31,321	19,094
Income taxes	(823)	(288)
Supplemental disclosures of noncash investing and financing activities
Loans transferred to other real estate	183	648
Initial recognition of right-of-use assets	729	0
Initial recognition of lease liabilities	$ 729	$ 0